Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
89.00    0.00 (0.00%)
Bid:
88.00
Ask:
90.00
Spread: 2.00 (2.273%)
Market Cap: £59.71m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Directors Dealings

28 Jul 2021 14:40

RNS Number : 7981G
Eco Animal Health Group PLC
28 July 2021
 

28 July 2021

 

 

ECO Animal Health Group PLC

("ECO" or "the Company")

 

Directors Dealings

 

ECO Animal Health Group plc was notified today that on 28 July 2021 the following Director purchases of ordinary shares of 5p each in the capital of the Company ("Ordinary Shares") were made.

 

Dr Andrew Jones, Non-Executive Chairman of the Company, purchased 7,500 Ordinary Shares at a price of 330 pence per Ordinary Share. As a result of this transaction, Dr Jones' total shareholding in the Company comprises 7,500 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.

 

Dr Frank Armstrong, a Non-Executive Director of the Company, purchased 3,000 Ordinary Shares at a price of 324 pence per Ordinary Share. As a result of this transaction, Dr Armstrong's total shareholding in the Company comprises 3,000 Ordinary Shares, representing approximately 0.004 per cent. of the Company's issued share capital.

 

Christopher Wilks, Chief Financial Officer of the Company, purchased 7,500 Ordinary Shares at a price of 330 pence per Ordinary Share. As a result of this transaction, Christopher Wilks' total shareholding in the Company comprises 7,500 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.

For further information please contact:

ECO Animal Health Group plc

Marc Loomes (CEO)

Christopher Wilks (CFO)

 

020 8447 8899

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

Iqra Amin

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

020 7418 8900

 

 

 

PDMR Notification

The notification below is made in accordance with the requirements of MAR

Acquisition of Ordinary Shares

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Andrew Jones

 

2.

Reason for the notification

a.

Position/status

Non-Executive Chairman

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

330.00p

7,500

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Frank Armstrong

 

2.

Reason for the notification

a.

Position/status

Non-Executive Director

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

324.00p

3,000

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Wilks

 

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

330.00p

7,500

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADXPAADFEFA
Date   Source Headline
4th Jun 20267:00 amRNSRenewal of revolving credit facility
14th Apr 20267:00 amRNSAppointment of Head of Business Development
31st Mar 20267:00 amRNSBoard Change
19th Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSECOVAXXIN® MG favourable USDA safety assessment
11th Mar 20267:00 amRNSECOVAXXIN®?MG favourable USDA safety assessment
5th Mar 20264:19 pmRNSBlock Listing Return
26th Feb 20267:00 amRNSEU launch plans for ECOVAXXIN® MS
19th Jan 20261:50 pmRNSHolding(s) in Company
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
18th Dec 20257:00 amRNSExercise of Share Options by Director
9th Dec 20255:57 pmRNSHolding(s) in Company
4th Dec 20252:10 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
20th Nov 20259:47 amRNSReplacement: Notice of Results
20th Nov 20257:00 amRNSNotice of Results
10th Nov 20257:00 amRNSEMA Positive Opinion Received for ECOVAXXIN® MS
1st Oct 20257:00 amRNS-RHead of Global R&D
25th Sep 20253:15 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Trading Update and Notice of Interim Results
1st Sep 20257:00 amRNSAppointment of Joint Broker
29th Aug 20257:00 amRNSShare Awards to Executive Directors
28th Aug 20257:48 amRNSPosting of Annual Report and Notice of AGM
21st Aug 202512:29 pmRNSResult of General Meeting
13th Aug 20257:00 amRNSBlock Listing Return
6th Aug 20255:09 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSResults for the year ended 31 March 2025
8th Jul 20254:10 pmRNSNotice of General Meeting and Notice of Results
2nd May 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Update
13th Mar 20257:00 amRNSR&D Day
3rd Mar 20257:00 amRNSSubmission of Marketing Authorisation Application
24th Feb 20254:08 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSDisposal of non-core assets
18th Feb 20257:00 amRNSBlock listing Interim Review
13th Feb 20257:00 amRNSNotice of R&D Day
31st Jan 20257:00 amRNSBoard Changes
20th Dec 20247:00 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:30 pmRNSShare Purchase by Executive Director
28th Nov 20247:00 amRNSResults for the Six Months Ended 30 September 2024
28th Oct 202412:57 pmRNSShare Awards to Executive Directors
22nd Oct 202411:00 amRNSEBT Share Purchase
21st Oct 20247:00 amRNSEBT Share Purchase
14th Oct 202411:07 amRNSEBT Share Purchase
9th Oct 20247:00 amRNSIssue of Equity and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.